Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Cooper

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Annals of Hematology|July 24, 2024
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national databaseJohn Yan, M Bakri Hammami, John X Wei, et al.
Blood Cancer Journal|August 21, 2025
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratificationRajvi Gor, Jeevan Shivakumar, Pallavi Surana, et al.
Blood|April 15, 2015
Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targetsKartik Sehgal, Rituparna Das, Lin Zhang, et al.
JMIR Cancer|January 6, 2026
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot StudyLemchukwu Amaeshi, Lauren Laufer, Kateryna Fedorov, et al.
Blood Cancer Journal|March 5, 2024
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world studyMeera Mohan, Jorge Monge, Nishi Shah, et al.
Stem Cell Investigation|September 4, 2023
Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohortHiba Narvel, Charan Vegivinti, Sindhu Vikash, et al.
British Journal of Haematology|August 28, 2024
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodiesOthman Salim Akhtar, Aniko Szabo, Vineel Bhatlapenumarthi, et al.
JCO Precision Oncology|July 25, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected CasesNishi Shah, Melissa Suchanek, Astha Thakkar, et al.
Clinical Hematology International|March 15, 2023
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/LymphomaAbdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Annals of Hematology|July 24, 2024
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national databaseJohn Yan, M Bakri Hammami, John X Wei, et al.
Blood Cancer Journal|August 21, 2025
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratificationRajvi Gor, Jeevan Shivakumar, Pallavi Surana, et al.
Blood|April 15, 2015
Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targetsKartik Sehgal, Rituparna Das, Lin Zhang, et al.
JMIR Cancer|January 6, 2026
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot StudyLemchukwu Amaeshi, Lauren Laufer, Kateryna Fedorov, et al.
Blood Cancer Journal|March 5, 2024
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world studyMeera Mohan, Jorge Monge, Nishi Shah, et al.
Stem Cell Investigation|September 4, 2023
Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohortHiba Narvel, Charan Vegivinti, Sindhu Vikash, et al.
British Journal of Haematology|August 28, 2024
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodiesOthman Salim Akhtar, Aniko Szabo, Vineel Bhatlapenumarthi, et al.
JCO Precision Oncology|July 25, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected CasesNishi Shah, Melissa Suchanek, Astha Thakkar, et al.
Clinical Hematology International|March 15, 2023
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/LymphomaAbdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel, et al.
Pageof 4